CN110772723A - Skin tissue treatment system - Google Patents
Skin tissue treatment system Download PDFInfo
- Publication number
- CN110772723A CN110772723A CN201911069364.4A CN201911069364A CN110772723A CN 110772723 A CN110772723 A CN 110772723A CN 201911069364 A CN201911069364 A CN 201911069364A CN 110772723 A CN110772723 A CN 110772723A
- Authority
- CN
- China
- Prior art keywords
- data
- pulse signal
- characteristic
- treatment system
- basic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0017—Wound healing
Abstract
The invention relates to the field of wound surface skin tissue engineering repair, in particular to a skin tissue treatment system, wherein: the pulse signal transmitting unit is used for receiving basic data and forming target data output matched with the basic data according to the basic data; the conversion unit is connected with the pulse signal transmitting unit and used for receiving the target data and forming ultrasonic data matched with the target data according to the target data; and the output unit is connected with the conversion unit and used for receiving the ultrasonic data and projecting the ultrasonic data to a target area matched with the basic data.
Description
Technical Field
The invention relates to the field of wound surface skin tissue engineering repair, in particular to a skin tissue treatment system.
Background
The wound surface refers to the comprehensive manifestation of the damage of the skin integrity caused by the combined action of intrinsic factors such as local blood flow obstruction and external factors such as heat source, chemical substances, external force, current and the like. Wound repair is a complex project, including inflammatory reaction, cell proliferation, wound contraction and other steps, for example, if the condition affecting tissue repair, such as diabetes, malnutrition and other diseases, causes delayed wound repair, chronic wounds are easily formed due to delayed wound repair, the chronic wounds can increase infection risks to endanger life, and peripheral tissue contracture, pain and aggravation of diseases are promoted, so that not only is the economic burden of patients increased, but also the great challenge of doctors in clinical work is realized, and the finding of a new method for promoting tissue repair is of great significance.
At present, the main treatment methods for promoting wound repair are available; the technology is characterized in that the treatment method has high requirements on equipment and high treatment cost; secondly, treating the wound by growth factors, wherein the growth factors have chemotactic effect, and promote cell proliferation and vascularization of the wound by attracting inflammatory cells and fibroblasts into the wound; the preparation method has the advantages that the preparation method has a regulating effect on the generation and degradation of extracellular matrix and induces adjacent cells to synthesize cytokines, but growth factors belong to genetic engineering pharmacy, many pharmacology and toxicology are not completely researched, many problems in clinical application are further solved, and meanwhile, the treatment method is high in treatment cost and cannot be popularized widely; and thirdly, ultraviolet rays are irradiated, and the ultraviolet rays destroy DNA in bacterial cell nuclei on the surface of the wound surface, so that the bacterial DNA is inhibited to generate a treatment effect, but the method has high requirement on the treatment dosage, and can damage the DNA of normal cells under the condition of improper dosage.
Disclosure of Invention
In view of the above technical problems of wound repair, the present invention provides a skin tissue treatment system.
In particular, the amount of the solvent to be used,
a dermal tissue treatment system, wherein: comprises the steps of (a) preparing a mixture of a plurality of raw materials,
the pulse signal transmitting unit is used for receiving basic data and forming target data output matched with the basic data according to the basic data;
the conversion unit is connected with the pulse signal transmitting unit and used for receiving the target data and forming ultrasonic data matched with the target data according to the target data, and the sound intensity threshold range of the ultrasonic data is 30mW/cm
2-500mW/cm
2；
And the output unit is connected with the conversion unit and used for receiving the ultrasonic data and projecting the ultrasonic data to a target area matched with the basic data.
Preferably, the skin tissue treatment system further comprises:
and the acquisition unit is connected with the pulse signal transmitting unit and used for acquiring reference data of a target area, forming the basic data according to the reference data and outputting the basic data to the pulse signal transmitting unit.
Preferably, in the skin tissue treatment system, the reference data includes a first characteristic reference value and a second characteristic reference value, and the basic data includes a first characteristic basic value and a second characteristic basic value;
the acquisition unit forms the first characteristic basic value according to the first characteristic reference value in the state of acquiring the first characteristic reference value; alternatively, the first and second electrodes may be,
and forming the second characteristic basic value according to the second characteristic reference value in the state of acquiring the second characteristic reference value.
Preferably, in the skin tissue treatment system according to the above, the pulse signal transmitting unit includes at least:
the pulse signal generator is used for receiving the first characteristic basic value and forming first pulse signal data output according to the first characteristic basic value; or, the second pulse signal data output is formed according to the second characteristic basic value after the second characteristic basic value is received;
and the amplifier is connected with the pulse signal generator and used for receiving the first pulse signal data or the second pulse signal data and amplifying the first pulse signal data or the second pulse signal data to form the first type of target data or the second type of target data to be output.
Preferably, the skin tissue treatment system further comprises a fixing device for accommodating the conversion unit.
Preferably, in the skin tissue treatment system, the fixing device further includes a filling area inside, the filling area is disposed adjacent to the converting unit, and an opening of the filling area faces away from the converting unit.
Preferably, the skin tissue treatment system further comprises a filling area for accommodating the filling medium.
Preferably, in the skin tissue treatment system, the filling medium at least includes deionized water, a coupling agent, and PVA.
Compared with the prior art, the invention has the advantages that: wound surface data information is collected clinically or mechanically, an electric pulse signal is formed according to the wound surface data information and is output, a conversion unit converts the electric pulse signal into an ultrasonic signal, the ultrasonic signal is output through an output unit and acts on an area where a wound surface is located, and the sound intensity threshold range of the ultrasonic data is 30mW/cm
2-500mW/cm
2. When the sound intensity of the ultrasonic data is set to be 30mW/cm
2To 500mW/cm
2In addition, the ultrasonic wave can inhibit tumorThe ultrasonic wave treatment system is a purely physical treatment method, has strong penetrability, has the advantages of accuracy and non-wound, and has high cost performance and relatively low requirements on instruments and equipment.
Drawings
Fig. 1 is a schematic structural diagram of a dermal tissue treatment system according to an embodiment of the present invention.
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings and examples. It is to be understood that the specific embodiments described herein are merely illustrative of the invention and are not limiting of the invention. It should be further noted that, for the convenience of description, only some of the structures related to the present invention are shown in the drawings, not all of the structures.
Example one
As shown in fig. 1, a skin tissue treatment system is mainly used for treating wound skin, wherein: comprises the steps of (a) preparing a mixture of a plurality of raw materials,
the pulse signal transmitting unit is used for receiving basic data and forming target data output matched with the basic data according to the basic data; the basic data can be directly obtained clinically or obtained by an acquisition unit, and for example, the basic data at least includes information of the area of the wound surface, the healing state of the wound surface and the nutritional state of the patient. The basic data can be divided into at least two types of data, such as refractory wound data and general wound data. The target data is output as an electric pulse signal.
The conversion unit is connected with the pulse signal transmitting unit and used for receiving the target data and forming ultrasonic data matched with the target data according to the target data; the ultrasound data is in the form of ultrasound wavesOutputting, wherein the frequency of the ultrasonic wave is not less than 20000Hz, and the threshold range of the sound intensity of the ultrasonic data is 30mW/cm
2-500mW/cm
2. When the sound intensity of the ultrasonic data is set to be 30mW/cm
2To 500mW/cm
2In addition, the ultrasonic wave can inhibit the production of tumor necrosis factor α (TNF α) and interleukin 1 β (IL-1 β), and promote the generation of wound collagen, fibroblast proliferation and angiogenesis.
And the output unit is connected with the conversion unit and used for receiving the ultrasonic data and projecting the ultrasonic data to a target area matched with the basic data. The target area is the area where the wound surface is located.
The specific working principle of the skin tissue treatment system is as follows: wound surface data information is collected clinically or mechanically, an electric pulse signal is formed according to the wound surface data information and is output, a conversion unit converts the electric pulse signal into an ultrasonic signal, the ultrasonic signal is output through an output unit and acts on an area where a wound surface is located, and the sound intensity threshold range of the ultrasonic data is 30mW/cm
2-500mW/cm
2. When the sound intensity of the ultrasonic data is set to be 30mW/cm
2To 500mW/cm
2The ultrasonic wave can inhibit the generation of tumor necrosis factor α (TNF α) and interleukin 1 β (IL-1 β), promote the generation of wound collagen, promote the proliferation of fibroblasts and angiogenesis, further the ultrasonic wave effectively improves the local blood perfusion of wound tissue, promotes the angiogenesis and tissue repair to realize the witness of wound skin, and the ultrasonic repair treatment is carried out on the wound skin through a skin tissue treatment system, is a purely physical treatment method, has strong penetrability, has the advantages of precision and non-wound, has higher cost performance and relatively lower requirements on instruments and equipment.
As a further preferred embodiment, the skin tissue treatment system described above, further comprising:
and the acquisition unit is connected with the pulse signal transmitting unit and used for acquiring reference data of a target area, forming the basic data according to the reference data and outputting the basic data to the pulse signal transmitting unit. Further, the reference data includes a first characteristic reference value and a second characteristic reference value, for example, when the area of the wound is large, the type of the wound is a chronic wound, and the patient is malnourished, the first characteristic reference value is defined as a refractory wound, and otherwise, the second characteristic reference value is defined as a normal wound. The basic data comprises a first characteristic basic value and a second characteristic basic value; when the reference data is a first characteristic reference value, the first characteristic basic value is the healing-refractory wound surface data; and when the reference data is a second characteristic reference value, the second characteristic basic value is the common wound surface data.
The acquisition unit forms the first characteristic basic value according to the first characteristic reference value in the state of acquiring the first characteristic reference value; alternatively, the first and second electrodes may be,
and forming the second characteristic basic value according to the second characteristic reference value in the state of acquiring the second characteristic reference value.
As a further preferred embodiment, the skin tissue treatment system as described above, wherein the pulse signal transmitting unit includes at least:
the pulse signal generator is used for receiving the first characteristic basic value and forming first pulse signal data output according to the first characteristic basic value; or, the second pulse signal data output is formed according to the second characteristic basic value after the second characteristic basic value is received;
and the amplifier is connected with the pulse signal generator and used for receiving the first pulse signal data or the second pulse signal data and amplifying the first pulse signal data or the second pulse signal data to form the first type of target data or the second type of target data to be output. The first type of target data and the second type of target data may be selected according to specific practical applications, and are not specifically described herein.
It should be noted that the conversion unit may include multiple transduction devices, and different transduction devices are selected according to different target data, for example, when the wound area is large and the wound depth is shallow, a planar array transduction device is selected, and a higher ultrasonic frequency is used for treatment, and when the wound area is small and the wound depth is deep, an arc array transduction device is selected, and a lower ultrasonic frequency is used for treatment; illustratively, the acute phase is selected to have a lower ultrasound intensity, which may be adjusted higher if the healing is good and in the non-acute phase.
As a further preferred embodiment, the skin tissue treatment system further comprises a fixing device for accommodating the converting unit, and further, the converting unit is fixed in the fixing device through a sterile membrane. The fixing device is characterized in that the fixing device also comprises a filling area, the filling area is adjacent to the conversion unit, and an opening of the filling area faces away from the conversion unit. The filling area is used for containing the filling medium. The filling medium at least comprises deionized water, coupling agent and PVA. The ultrasound is brought to the treatment area by filling the medium.
It is to be noted that the foregoing is only illustrative of the preferred embodiments of the present invention and the technical principles employed. It will be understood by those skilled in the art that the present invention is not limited to the particular embodiments described herein, but is capable of various obvious changes, rearrangements and substitutions as will now become apparent to those skilled in the art without departing from the scope of the invention. Therefore, although the present invention has been described in greater detail by the above embodiments, the present invention is not limited to the above embodiments, and may include other equivalent embodiments without departing from the spirit of the present invention, and the scope of the present invention is determined by the scope of the appended claims.
Although various aspects of the invention are presented in the independent claims, other aspects of the invention comprise combinations of features from the described embodiments and/or the dependent claims with the features of the independent claims, and not solely the combinations explicitly presented in the claims.
It is noted herein that while the above describes example embodiments of the invention, these descriptions should not be viewed in a limiting sense. Rather, several variations and modifications are possible without departing from the scope of the invention as defined in the appended claims.
It is to be noted that the foregoing is only illustrative of the preferred embodiments of the present invention and the technical principles employed. It will be understood by those skilled in the art that the present invention is not limited to the particular embodiments described herein, but is capable of various obvious changes, rearrangements and substitutions as will now become apparent to those skilled in the art without departing from the scope of the invention. Therefore, although the present invention has been described in greater detail by the above embodiments, the present invention is not limited to the above embodiments, and may include other equivalent embodiments without departing from the spirit of the present invention, and the scope of the present invention is determined by the scope of the appended claims.
Claims (8)
1. A dermal tissue treatment system, characterized by: comprises the steps of (a) preparing a mixture of a plurality of raw materials,
the pulse signal transmitting unit is used for receiving basic data and forming target data output matched with the basic data according to the basic data;
the conversion unit is connected with the pulse signal transmitting unit and used for receiving the target data and forming ultrasonic data matched with the target data according to the target data, and the sound intensity threshold range of the ultrasonic data is 30mW/cm
2-500mW/cm
2；
And the output unit is connected with the conversion unit and used for receiving the ultrasonic data and projecting the ultrasonic data to a target area matched with the basic data.
2. The dermal tissue treatment system of claim 1, further comprising:
and the acquisition unit is connected with the pulse signal transmitting unit and used for acquiring reference data of a target area, forming the basic data according to the reference data and outputting the basic data to the pulse signal transmitting unit.
3. A dermal tissue treatment system according to claim 1, characterized in that the reference data comprise a first characteristic reference value, a second characteristic reference data, the basis data comprise a first characteristic basis value, a second characteristic basis value;
the acquisition unit forms the first characteristic basic value according to the first characteristic reference value in the state of acquiring the first characteristic reference value; alternatively, the first and second electrodes may be,
and forming the second characteristic basic value according to the second characteristic reference value in the state of acquiring the second characteristic reference value.
4. A dermal tissue treatment system according to claim 3, characterized in that: the pulse signal transmitting unit includes at least:
the pulse signal generator is used for receiving the first characteristic basic value and forming first pulse signal data output according to the first characteristic basic value; or, the second pulse signal data output is formed according to the second characteristic basic value after the second characteristic basic value is received;
and the amplifier is connected with the pulse signal generator and used for receiving the first pulse signal data or the second pulse signal data and amplifying the first pulse signal data or the second pulse signal data to form the first type of target data or the second type of target data to be output.
5. The dermal tissue treatment system of claim 1, wherein: the device also comprises a fixing device used for accommodating the conversion unit.
6. The dermal tissue treatment system of claim 5, wherein: the fixing device is characterized in that the fixing device also comprises a filling area, the filling area is adjacent to the conversion unit, and an opening of the filling area faces away from the conversion unit.
7. The dermal tissue treatment system of claim 6, wherein: the filling area is used for containing the filling medium.
8. The dermal tissue treatment system of claim 7, wherein: the filling medium at least comprises deionized water, coupling agent and PVA.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911069364.4A CN110772723A (en) | 2019-11-08 | 2019-11-08 | Skin tissue treatment system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911069364.4A CN110772723A (en) | 2019-11-08 | 2019-11-08 | Skin tissue treatment system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110772723A true CN110772723A (en) | 2020-02-11 |
Family
ID=69388925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911069364.4A Pending CN110772723A (en) | 2019-11-08 | 2019-11-08 | Skin tissue treatment system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110772723A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101505706A (en) * | 2006-06-26 | 2009-08-12 | 艾拉兹·巴巴耶夫 | Ultrasound wound care device and method |
| CN103096976A (en) * | 2009-12-31 | 2013-05-08 | 杰拓奥兹有限责任公司 | Portable ultrasound system |
| CN103384548A (en) * | 2010-12-22 | 2013-11-06 | 伊兰·费非博格 | Skin ulcer treatment |
| CN103919638A (en) * | 2013-01-15 | 2014-07-16 | 拉达克里希南·瑞曼达 | Portable Electronic Therapy Device And The Method Thereof |
| US20170128740A1 (en) * | 2015-11-11 | 2017-05-11 | Qc, Llc | Phototherapy device with real-time morphologic feedback and guidance |
| EP2395958B1 (en) * | 2009-02-12 | 2017-12-13 | Perfuzia Medical, Inc. | Devices for manipulating circulation in the circulatory system of a patient |
| CN109069712A (en) * | 2016-05-13 | 2018-12-21 | 史密夫及内修公开有限公司 | Enable the wound monitoring and therapy devices of sensor |
| CN208552614U (en) * | 2017-10-23 | 2019-03-01 | 广东美捷威通生物科技有限公司 | A kind of Wound treating micro-vacuum system |
-
2019
- 2019-11-08 CN CN201911069364.4A patent/CN110772723A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101505706A (en) * | 2006-06-26 | 2009-08-12 | 艾拉兹·巴巴耶夫 | Ultrasound wound care device and method |
| EP2395958B1 (en) * | 2009-02-12 | 2017-12-13 | Perfuzia Medical, Inc. | Devices for manipulating circulation in the circulatory system of a patient |
| CN103096976A (en) * | 2009-12-31 | 2013-05-08 | 杰拓奥兹有限责任公司 | Portable ultrasound system |
| CN103384548A (en) * | 2010-12-22 | 2013-11-06 | 伊兰·费非博格 | Skin ulcer treatment |
| CN103919638A (en) * | 2013-01-15 | 2014-07-16 | 拉达克里希南·瑞曼达 | Portable Electronic Therapy Device And The Method Thereof |
| US20170128740A1 (en) * | 2015-11-11 | 2017-05-11 | Qc, Llc | Phototherapy device with real-time morphologic feedback and guidance |
| CN109069712A (en) * | 2016-05-13 | 2018-12-21 | 史密夫及内修公开有限公司 | Enable the wound monitoring and therapy devices of sensor |
| CN208552614U (en) * | 2017-10-23 | 2019-03-01 | 广东美捷威通生物科技有限公司 | A kind of Wound treating micro-vacuum system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Song et al. | Omnidirectional ultrasonic powering for millimeter-scale implantable devices | |
| CN204601410U (en) | Multifrequency ring battle array probe and comprise its ultrasonic physiotherapy table | |
| EP0619104A1 (en) | Ultrasonic irradiation apparatus and processor using the same | |
| CN107913477B (en) | Excitation method, device, equipment and storage medium of array ultrasonic transducer | |
| CN108144199A (en) | Device, method and system are motivated by ultrasound | |
| CN1901837A (en) | Component ultrasound transducer | |
| CN111589001B (en) | Array type ultrasonic therapy system | |
| CN112029725B (en) | Method for promoting macrophage polarization to M1 type by utilizing piezoelectric effect and application | |
| TW201822723A (en) | Electromagnetic wave treatment device and use method thereof | |
| CN1073453C (en) | In vitro supersonic therapeutical instrument for medical purpose | |
| CN101869486B (en) | Ultrasonic diagnosis and treatment integrated machine | |
| CN110772723A (en) | Skin tissue treatment system | |
| CN202223256U (en) | Monitoring device for working state of ultrasonic transducer | |
| CN102451525A (en) | Ultrasonic treatment equipment | |
| CN212700070U (en) | Novel transducer and ultrasonic wave leading-in instrument | |
| CN211301814U (en) | Wearable flexible ultrasonic urethra scar therapeutic instrument | |
| CN202236919U (en) | Ultrasonic fat reducing treatment head | |
| CN104001277A (en) | Complex frequency ultrasonic tumor treatment head | |
| CN215025426U (en) | Multi-frequency ultrasonic transducer probe for ultrasonic tumor therapeutic instrument | |
| CN107497062A (en) | Focusing ultrasound fat melting system based on noninvasive temperature monitoring | |
| CN102989089A (en) | Ultrasonic focusing device for treating Parkinson's disease | |
| TWI337087B (en) | ||
| CN111249614A (en) | Novel transducer and ultrasonic wave leading-in instrument | |
| CN1079270C (en) | Method for treating tumour with ultrasonic onhanced sensitivity and its apparatus | |
| CN103272328A (en) | XP embedded physiotherapy instrument system based on bioelectrical impedance mechanism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200211 |
|
| RJ01 | Rejection of invention patent application after publication |